# Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

> **NCT01271348** · PHASE1 · COMPLETED · sponsor: **X-pert Med GmbH** · enrollment: 50 (estimated)

## Conditions studied

- Muscle Pain

## Interventions

- **DRUG:** Etoricoxib
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01271348
- **Lead sponsor:** X-pert Med GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01271348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01271348, "Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01271348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*